Time until Need for Levodopa among New Users of Dopamine Agonists or MAO-B Inhibitors

OBJECTIVE: To investigate the use of dopamine agonists and monoamine oxidase type B (MAO-B) inhibitors in the Norwegian population, between 1 July 2006 and 31 December 2016. Our primary endpoint was time until need for levodopa among new monotherapy users of dopamine agonists and MAO-B inhibitors. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Binde, Caroline D., Tvete, Ingunn F., Klemp, Marianne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270692/
https://www.ncbi.nlm.nih.gov/pubmed/34306611
http://dx.doi.org/10.1155/2021/9952743

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270692/
https://www.ncbi.nlm.nih.gov/pubmed/34306611
http://dx.doi.org/10.1155/2021/9952743

Ejemplares similares